{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:04:45Z","timestamp":1793084685576,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02225-2","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T09:53:37Z","timestamp":1747648417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Incidence of medication-related osteonecrosis of the jaw and associated antiresorptive drugs in adult Finnish population"],"prefix":"10.1038","volume":"15","author":[{"given":"Miika","family":"Kujanp\u00e4\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville","family":"Vuollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Tiisanoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja-Liisa","family":"Laitala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy K.","family":"S\u00e1ndor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saujanya","family":"Karki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"2225_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero, S. L. et al. American association of oral and maxillofacial surgeons position paper on Medication-Related osteonecrosis of the Jaw\u20142014 update. J. Oral Maxillofac. Surg. 72, 1938\u20131956 (2014).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"2225_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jcms.2017.11.008","volume":"46","author":"VL Poubel","year":"2018","unstructured":"Poubel, V. L. et al. C. The risk of osteonecrosis on alveolar healing after tooth extraction and systemic administration of antiresorptive drugs in rodents: a systematic review. J. Cranio-Maxillofacial Surg. 46, 245\u2013256 (2018).","journal-title":"J. Cranio-Maxillofacial Surg."},{"key":"2225_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11912-021-01047-5","volume":"23","author":"A Basu Mallick","year":"2021","unstructured":"Basu Mallick, A. & Chawla, S. P. Giant cell tumor of bone: an update. Curr. Oncol. Rep. 23, 51 (2021).","journal-title":"Curr. Oncol. Rep."},{"key":"2225_CR4","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero, S. L. et al. American association of oral and maxillofacial surgeons\u2019 position paper on Medication-Related osteonecrosis of the Jaws\u20142022 update. J. Oral Maxillofac. Surg. 80, 920\u2013943 (2022).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"2225_CR5","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx, R. E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J. Oral Maxillofac. Surg. 61, 1115\u20131117 (2003).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"2225_CR6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00520-010-0882-1","volume":"18","author":"CA Migliorati","year":"2010","unstructured":"Migliorati, C. A. et al. A systematic review of bisphosphonate osteonecrosis (BON) in cancer. Support. Care Cancer. 18, 1099\u20131106 (2010).","journal-title":"Support. Care Cancer"},{"key":"2225_CR7","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s00520-020-05882-3","volume":"29","author":"A Srivastava","year":"2021","unstructured":"Srivastava, A. et al. Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis. Support. Care Cancer. 29, 2305\u20132317 (2021).","journal-title":"Support. Care Cancer"},{"key":"2225_CR8","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3109\/00016357.2013.764007","volume":"71","author":"TB Kr\u00fcger","year":"2013","unstructured":"Kr\u00fcger, T. B., Sharikabad, M. N. & Herlofson, B. B. Bisphosphonate-related osteonecrosis of the jaw in four nordic countries and an indication of under-reporting. Acta Odontol. Scand. 71, 1386\u20131390 (2013).","journal-title":"Acta Odontol. Scand."},{"key":"2225_CR9","doi-asserted-by":"publisher","unstructured":"Limones, A. et al. Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis. Med. Oral Patol. Oral Cir. Bucal. e326\u2013e336. https:\/\/doi.org\/10.4317\/medoral.23324 (2020).","DOI":"10.4317\/medoral.23324"},{"key":"2225_CR10","unstructured":"Social Insurance Institution. Finnish statistics on medicines. (2016). https:\/\/www.julkari.fi\/handle\/10024\/135599"},{"key":"2225_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad, F. et al. Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann. Oncol. 23, 1341\u20131347 (2012).","journal-title":"Ann. Oncol."},{"key":"2225_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.oooo.2020.04.808","volume":"130","author":"F Hallmer","year":"2020","unstructured":"Hallmer, F., Bjarnadottir, O., G\u00f6trick, B., Malmstr\u00f6m, P. & Andersson, G. Incidence of and risk factors for medication-related osteonecrosis of the jaw in women with breast cancer with bone metastasis: a population-based study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 130, 252\u2013257 (2020).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"2225_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/0284186X.2016.1262548","volume":"56","author":"L Vehmanen","year":"2017","unstructured":"Vehmanen, L., Suojanen, J., Kontio, R., Utriainen, T. & Blomqvist, C. High frequency of osteonecrosis of the jaw among denosumab-treated prostate cancer patients. Acta Oncol. (Madr). 56, 104\u2013106 (2017).","journal-title":"Acta Oncol. (Madr)"},{"key":"2225_CR14","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/odi.12842","volume":"24","author":"J Coello-Suanzes","year":"2018","unstructured":"Coello-Suanzes, J. et al. Preventive dental management of osteonecrosis of the jaws related to Zoledronic acid treatment. Oral Dis. 24, 1029\u20131036 (2018).","journal-title":"Oral Dis."},{"key":"2225_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.oooo.2018.08.015","volume":"126","author":"F Hallmer","year":"2018","unstructured":"Hallmer, F. et al. Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw\u2014a 4-year prospective study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 126, 477\u2013485 (2018).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"2225_CR16","unstructured":"Finlex Act on the Secondary Use of Health and Social Data, Finland. (2019). https:\/\/www.finlex.fi\/en\/legislation\/2019\/552#Text%20of%20statute"},{"key":"2225_CR17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/scd.12893","volume":"44","author":"I Khan","year":"2024","unstructured":"Khan, I. Medication-related osteonecrosis of the external auditory canal \u2013 A rapid review of the literature and relevance to special care dentists. Spec. Care Dentist. 44, 314\u2013327 (2024).","journal-title":"Spec. Care Dentist."},{"key":"2225_CR18","doi-asserted-by":"publisher","first-page":"e025600","DOI":"10.1136\/bmjopen-2018-025600","volume":"9","author":"E Veszelyn\u00e9 Kot\u00e1n","year":"2019","unstructured":"Veszelyn\u00e9 Kot\u00e1n, E. et al. Database analysis of the risk factors of bisphosphonate-related osteonecrosis of the jaw in Hungarian patients. BMJ Open. 9, e025600 (2019).","journal-title":"BMJ Open."},{"key":"2225_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.12701\/jyms.2023.01116","volume":"41","author":"SY Ko","year":"2024","unstructured":"Ko, S. Y., Hwang, T. Y., Baek, K. & Park, C. Incidence and severity of medication-related osteonecrosis of the jaw in patients with osteoporosis using data from a Korean nationwide sample cohort in 2002 to 2019: a retrospective study. J. Yeungnam Med. Sci. 41, 39\u201344 (2024).","journal-title":"J. Yeungnam Med. Sci."},{"key":"2225_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","volume":"127","author":"O Nicolatou-Galitis","year":"2019","unstructured":"Nicolatou-Galitis, O. et al. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 127, 117\u2013135 (2019).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"2225_CR21","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1016\/j.ajpath.2014.07.010","volume":"184","author":"DW Williams","year":"2014","unstructured":"Williams, D. W. et al. Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the Jaw-Like lesions by bisphosphonate and Anti\u2013Receptor activator of NF-\u03baB ligand antibody in mice. Am. J. Pathol. 184, 3084\u20133093 (2014).","journal-title":"Am. J. Pathol."},{"key":"2225_CR22","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.oooo.2018.02.003","volume":"125","author":"AA Owosho","year":"2018","unstructured":"Owosho, A. A. et al. Medication-related osteonecrosis of the jaw: an update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 125, 440\u2013445 (2018).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"2225_CR23","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1056\/NEJMc062792","volume":"356","author":"SE Papapoulos","year":"2007","unstructured":"Papapoulos, S. E. & Cremers, S. C. L. M. Prolonged bisphosphonate release after treatment in children. N. Engl. J. Med. 356, 1075\u20131076 (2007).","journal-title":"N. Engl. J. Med."},{"key":"2225_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.coms.2015.06.007","volume":"27","author":"WB Williams","year":"2015","unstructured":"Williams, W. B. & O\u2019Ryan, F. Management of Medication-Related osteonecrosis of the jaw. Oral Maxillofac. Surg. Clin. North. Am. 27, 517\u2013525 (2015).","journal-title":"Oral Maxillofac. Surg. Clin. North. Am."},{"key":"2225_CR25","doi-asserted-by":"crossref","unstructured":"Beth-Tasdogan, N. H., Mayer, B., Hussein, H., Zolk, O. & Peter, J. U. Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database of Systematic Reviews (2022). (2022).","DOI":"10.1002\/14651858.CD012432.pub3"},{"key":"2225_CR26","doi-asserted-by":"publisher","first-page":"175883592311731","DOI":"10.1177\/17588359231173180","volume":"15","author":"L Mastrantoni","year":"2023","unstructured":"Mastrantoni, L. et al. Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials. Ther. Adv. Med. Oncol. 15, 175883592311731 (2023).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"2225_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcph.2181","volume":"63","author":"Q Wang","year":"2023","unstructured":"Wang, Q., Yu, Q., Zeng, P. & Ai, W. Efficacy and safety of annual infusion of Zoledronic acid and weekly oral alendronate in the treatment of primary osteoporosis: A Meta-Analysis. J. Clin. Pharmacol. 63, 455\u2013465 (2023).","journal-title":"J. Clin. Pharmacol."},{"key":"2225_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/odi.12708","volume":"24","author":"K McGowan","year":"2018","unstructured":"McGowan, K., McGowan, T. & Ivanovski, S. Risk factors for medication-related osteonecrosis of the jaws: A systematic review. Oral Dis. 24, 527\u2013536 (2018).","journal-title":"Oral Dis."},{"key":"2225_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1159\/000447372","volume":"39","author":"F Chen","year":"2016","unstructured":"Chen, F. & Pu, F. Safety of denosumab versus Zoledronic acid in patients with bone metastases: A Meta-Analysis of randomized controlled trials. Oncol. Res. Treat. 39, 453\u2013459 (2016).","journal-title":"Oncol. Res. Treat."},{"key":"2225_CR30","doi-asserted-by":"crossref","unstructured":"Pinto, V. L., Fustinoni, S. M., Naz\u00e1rio, A. C. P., Facina, G. & Elias, S. Prevalence of Xerostomia in women during breast cancer chemotherapy. Rev. Bras. Enferm 73, (2020).","DOI":"10.1590\/0034-7167-2019-0785"},{"key":"2225_CR31","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1002\/cncr.33849","volume":"127","author":"P Aggarwal","year":"2021","unstructured":"Aggarwal, P. et al. Determinants of patient-reported Xerostomia among long-term oropharyngeal cancer survivors. Cancer 127, 4470\u20134480 (2021).","journal-title":"Cancer"},{"key":"2225_CR32","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1002\/cam4.2059","volume":"8","author":"C Chang","year":"2019","unstructured":"Chang, C. et al. Oral hygiene and the overall survival of head and neck cancer patients. Cancer Med. 8, 1854\u20131864 (2019).","journal-title":"Cancer Med."},{"key":"2225_CR33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00109-024-02425-9","volume":"102","author":"M Bassan","year":"2024","unstructured":"Bassan, M., Maciel, G., Marinho Maciel, R. & Linhares Ferrazzo, K. Cademartori Danesi, C. Etiopathogenesis of medication-related osteonecrosis of the jaws: a review. J. Mol. Med. 102, 353\u2013364 (2024).","journal-title":"J. Mol. Med."},{"key":"2225_CR34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3892\/etm.2021.11053","volume":"23","author":"Y Duan","year":"2021","unstructured":"Duan, Y. et al. VEGF mitigates bisphosphonateinduced apoptosis and differentiation Inhibition of MC3T3E1 cells. Exp. Ther. Med. 23, 130 (2021).","journal-title":"Exp. Ther. Med."},{"key":"2225_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000201931","volume":"76","author":"C Christodoulou","year":"2009","unstructured":"Christodoulou, C. et al. Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone. Oncology 76, 209\u2013211 (2009).","journal-title":"Oncology"},{"key":"2225_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11914-016-0318-z","volume":"14","author":"JAF Vermeer","year":"2016","unstructured":"Vermeer, J. A. F., Renders, G. A. P. & Everts, V. Osteonecrosis of the Jaw\u2014a bone Site-Specific effect of bisphosphonates. Curr. Osteoporos. Rep. 14, 219\u2013225 (2016).","journal-title":"Curr. Osteoporos. Rep."},{"key":"2225_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12020-011-9580-0","volume":"41","author":"RS Weinstein","year":"2012","unstructured":"Weinstein, R. S. Glucocorticoid-induced osteonecrosis. Endocrine 41, 183\u2013190 (2012).","journal-title":"Endocrine"},{"key":"2225_CR38","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1007\/s00520-022-06839-4","volume":"30","author":"H Hata","year":"2022","unstructured":"Hata, H. et al. Prognosis by cancer type and incidence of Zoledronic acid\u2013related osteonecrosis of the jaw: a single-center retrospective study. Support. Care Cancer. 30, 4505\u20134514 (2022).","journal-title":"Support. Care Cancer"},{"key":"2225_CR39","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s00784-020-03485-0","volume":"25","author":"A Tiisanoja","year":"2021","unstructured":"Tiisanoja, A., Syrj\u00e4l\u00e4, A. M., Anttonen, V. & Yl\u00f6stalo, P. Anticholinergic burden, oral hygiene practices, and oral hygiene status\u2014cross-sectional findings from the Northern Finland birth cohort 1966. Clin. Oral Investig. 25, 1829\u20131837 (2021).","journal-title":"Clin. Oral Investig"},{"key":"2225_CR40","unstructured":"World Health Organisation (n.d.a). International Statistical Classification of Diseases and Related Health Problems (ICD). https:\/\/www.who.int\/standards\/classifications\/classification-of-diseases"},{"key":"2225_CR41","unstructured":"World Health Organization (n.d.b). Anatomical Therapeutic Chemical (ATC) Classification."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02225-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02225-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02225-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T09:53:40Z","timestamp":1747648420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02225-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2225"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02225-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4177868\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17377"}}